Fusafungine
From Wikipedia, the free encyclopedia
|
Fusafungine
|
|
| Systematic (IUPAC) name | |
| ? | |
| Identifiers | |
| CAS number | |
| ATC code | R02 |
| PubChem | ? |
| Chemical data | |
| Formula | C29H51N2O8 |
| Mol. mass | 555.72 g/mol |
| Synonyms | Fusafungin |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Fusafungine (INN), also known as fusafungin, is an active agent used in antibiotics for treatment of nasal and throat infection. It also possesses anti-inflammatory properties. It is produced by the ascomycete Fusarium lateririum, and marketed by Servier under the trade name Locabiotal and Bioparox - in Austria, Germany and Switzerland under the tade name Locabiosol.
|
|||||||||||
 |
This antibiotic-related article is a stub. You can help Wikipedia by expanding it. |
